Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
CymaBay Therapeutics, Inc. (CBAY)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
12 Feb 2024
Dorling Janet
Director
CymaBay Therapeutics, Inc.
(CBAY)
0
-100%
6,000
$31.97
$191,848.80
SELL
19 Jan 2024
McWherter Charles
President of R&D, Officer
CymaBay Therapeutics, Inc.
(CBAY)
15,000
-55%
18,403
$23.67
$435,644.80
SELL
16 Jan 2024
Menold Daniel
Vice President, Finance, Officer
CymaBay Therapeutics, Inc.
(CBAY)
0
-100%
10,000
$23.58
$235,806.00
SELL
16 Jan 2024
Quinlan Paul T
General Counsel, Officer
CymaBay Therapeutics, Inc.
(CBAY)
0
-100%
5,000
$23.58
$117,898.00
SELL
10 Jan 2024
Dorling Janet
Director
CymaBay Therapeutics, Inc.
(CBAY)
0
-100%
6,000
$23.86
$143,144.40
SELL
18 Dec 2023
McWherter Charles
President of R&D, Officer
CymaBay Therapeutics, Inc.
(CBAY)
15,000
-43%
11,332
$21.48
$243,441.12
SELL
15 Dec 2023
Quinlan Paul T
General Counsel, Officer
CymaBay Therapeutics, Inc.
(CBAY)
0
-100%
5,000
$21.98
$109,902.50
SELL
15 Dec 2023
Menold Daniel
Vice President, Finance, Officer
CymaBay Therapeutics, Inc.
(CBAY)
0
-100%
21,497
$21.99
$472,646.50
SELL
17 Nov 2023
McWherter Charles
President of R&D, Officer
CymaBay Therapeutics, Inc.
(CBAY)
15,000
-43%
11,342
$18.28
$207,293.20
SELL
15 Nov 2023
Quinlan Paul T
General Counsel, Officer
CymaBay Therapeutics, Inc.
(CBAY)
0
-100%
5,000
$17.38
$86,889.00
SELL
18 Sep 2023
McWherter Charles
President of R&D, Officer
CymaBay Therapeutics, Inc.
(CBAY)
15,000
-59%
21,746
$16.22
$352,733.16
SELL
15 Sep 2023
Quinlan Paul T
General Counsel, Officer
CymaBay Therapeutics, Inc.
(CBAY)
0
-100%
53,000
$16.87
$894,140.80
SELL
18 Aug 2023
McWherter Charles
President of R&D, Officer
CymaBay Therapeutics, Inc.
(CBAY)
15,000
-59%
21,746
$11.47
$249,359.20
SELL
15 Aug 2023
Quinlan Paul T
General Counsel, Officer
CymaBay Therapeutics, Inc.
(CBAY)
0
-100%
5,000
$11.91
$59,550.50
SELL
9 Aug 2023
Menold Daniel
Vice President, Finance, Officer
CymaBay Therapeutics, Inc.
(CBAY)
0
-100%
20,945
$12.35
$258,744.06
SELL
14 Jul 2023
Quinlan Paul T
General Counsel, Officer
CymaBay Therapeutics, Inc.
(CBAY)
0
-100%
5,000
$11.81
$59,050.00
SELL
30 Jun 2023
Quinlan Paul T
General Counsel, Officer
CymaBay Therapeutics, Inc.
(CBAY)
0
-100%
5,000
$10.05
$50,250.00
SELL
20 Jun 2023
McWherter Charles
President of R&D, Officer
CymaBay Therapeutics, Inc.
(CBAY)
15,000
-59%
21,749
$8.16
$177,382.67
SELL
18 May 2023
McWherter Charles
President of R&D, Officer
CymaBay Therapeutics, Inc.
(CBAY)
15,000
-59%
21,749
$9.08
$197,387.39
SELL
15 May 2023
Quinlan Paul T
General Counsel, Officer
CymaBay Therapeutics, Inc.
(CBAY)
0
-100%
5,000
$10.37
$51,831.00
SELL
13 Apr 2023
KIM DENNIS D
Chief Medical Officer, Officer
CymaBay Therapeutics, Inc.
(CBAY)
20,000
-85%
120,000
$9.50
$1,140,415.90
SELL
28 Mar 2023
KIM DENNIS D
Chief Medical Officer, Officer
CymaBay Therapeutics, Inc.
(CBAY)
20,000
-0%
100
$8.99
$898.50
BUY
6 Jun 2022
Shah Sujal
Chief Executive Officer, Director, Officer
CymaBay Therapeutics, Inc.
(CBAY)
171,301
+42%
51,301
$1.95
$100,036.95
BUY
19 Jan 2022
KIM DENNIS D
Chief Medical Officer, Officer
CymaBay Therapeutics, Inc.
(CBAY)
20,000
+100%
20,000
$3.04
$60,800.00
BUY
10 Oct 2019
Shah Sujal
Chief Executive Officer, Director, Officer
CymaBay Therapeutics, Inc.
(CBAY)
120,000
+4%
5,000
$4.30
$21,500.00
BUY
20 Sep 2019
Shah Sujal
Chief Executive Officer, Director, Officer
CymaBay Therapeutics, Inc.
(CBAY)
115,000
+4%
5,000
$5.53
$27,655.00
SELL
7 Feb 2019
GOLDFISCHER CARL
Director
CymaBay Therapeutics, Inc.
(CBAY)
0
-100%
11,675
$9.02
$105,328.34
BUY
21 Dec 2018
Shah Sujal
Chief Executive Officer, Director, Officer
CymaBay Therapeutics, Inc.
(CBAY)
110,000
+10%
10,000
$6.54
$65,399.00
SELL
17 Dec 2018
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
131,036
-52%
142,381
$7.89
$1,123,588.50
BUY
15 Oct 2018
Shah Sujal
Chief Executive Officer, Director, Officer
CymaBay Therapeutics, Inc.
(CBAY)
100,000
+5%
5,000
$9.90
$49,500.00
SELL
29 Aug 2018
Menold Daniel
Vice President, Finance, Officer
CymaBay Therapeutics, Inc.
(CBAY)
0
-100%
5,000
$13.00
$65,000.00
BUY
27 Jul 2018
Shah Sujal
Chief Executive Officer, Director, Officer
CymaBay Therapeutics, Inc.
(CBAY)
95,000
+5%
5,000
$10.90
$54,500.00
SELL
5 Jun 2018
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
18,316
-4%
920
$12.51
$11,509.20
BUY
11 May 2018
Shah Sujal
Chief Executive Officer, Director, Officer
CymaBay Therapeutics, Inc.
(CBAY)
90,000
+5%
5,000
$10.65
$53,250.00
SELL
22 Mar 2018
GOLDFISCHER CARL
Director
CymaBay Therapeutics, Inc.
(CBAY)
0
-100%
15,000
$13.03
$195,375.00
SELL
5 Mar 2018
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
273,417
-4%
13,353
$15.51
$207,105.03
SELL
15 Feb 2018
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
286,770
-19%
68,712
$14.49
$995,636.90
SELL
13 Feb 2018
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
355,482
-38%
218,057
$15.89
$3,464,223.20
SELL
7 Feb 2018
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
419,693
-8%
40,763
$12.35
$503,423.06
SELL
5 Feb 2018
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
460,456
-3%
18,831
$12.14
$228,608.34
SELL
1 Feb 2018
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
479,287
-15%
90,098
$12.15
$1,094,610.60
SELL
30 Jan 2018
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
569,385
-14%
97,639
$12.22
$1,193,271.60
SELL
24 Jan 2018
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
667,024
-5%
39,438
$12.18
$480,354.84
SELL
22 Jan 2018
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
706,462
-16%
138,253
$10.40
$1,437,831.10
SELL
18 Jan 2018
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
844,715
-14%
144,216
$10.25
$1,477,668.80
SELL
5 Jan 2018
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
988,931
-0%
4,300
$10.21
$43,903.00
SELL
22 Dec 2017
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
993,231
-14%
173,192
$9.41
$1,629,303.80
SELL
10 Nov 2017
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
1,166,423
-4%
50,048
$9.26
$463,379.44
SELL
2 Nov 2017
GOLDFISCHER CARL
Director
CymaBay Therapeutics, Inc.
(CBAY)
0
-100%
18,000
$8.66
$155,880.00
BUY
2 Nov 2017
McWherter Charles
SVP & Chief Scientific Officer, Officer
CymaBay Therapeutics, Inc.
(CBAY)
10,300
+94%
5,000
$8.67
$43,340.60
SELL
1 Nov 2017
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
1,216,471
-0%
4,320
$9.25
$39,979.44
SELL
30 Oct 2017
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
1,220,791
-4%
59,209
$9.27
$548,801.06
SELL
2 Oct 2017
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
1,280,000
-7%
108,876
$7.85
$854,873.90
SELL
28 Sep 2017
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
1,388,876
-13%
211,124
$8.09
$1,707,379.80
BUY
1 Aug 2017
Wills Robert James
Director
CymaBay Therapeutics, Inc.
(CBAY)
25,200
+24%
5,000
$6.84
$34,220.70
BUY
20 Jul 2017
McWherter Charles
SVP & Chief Scientific Officer, Officer
CymaBay Therapeutics, Inc.
(CBAY)
5,100
+5000%
5,000
$7.43
$37,137.30
BUY
20 Jul 2017
Shah Sujal
Interim President & CEO, Director, Officer
CymaBay Therapeutics, Inc.
(CBAY)
75,891
+15%
10,000
$7.34
$73,400.50
BUY
19 Jul 2017
EMSTER KURT VON
Director
CymaBay Therapeutics, Inc.
(CBAY)
1,753,846
+9%
153,846
$6.50
$999,999.00
BUY
19 Jul 2017
Roger W. Marshall
Congressman (House)
CymaBay Therapeutics, Inc.
(CBAY)
N/A
N/A
N/A
$1,001 - $15,000
SELL
19 Jul 2017
Roger W. Marshall
Congressman (House)
CymaBay Therapeutics, Inc.
(CBAY)
N/A
N/A
N/A
$1,001 - $15,000
BUY
6 Sep 2016
Wills Robert James
Director
CymaBay Therapeutics, Inc.
(CBAY)
25,000
+100%
25,000
$2.43
$60,857.50
BUY
15 Apr 2016
OMara Patrick J.
VP, Business Development, Officer
CymaBay Therapeutics, Inc.
(CBAY)
5,022
+22727%
5,000
$1.64
$8,200.00
BUY
15 Apr 2016
McWherter Charles
Sr. Vice President, Officer
CymaBay Therapeutics, Inc.
(CBAY)
5,000
+150%
3,000
$1.68
$5,040.00
BUY
4 Apr 2016
Shah Sujal
Chief Financial Officer, Officer
CymaBay Therapeutics, Inc.
(CBAY)
75,000
+275%
55,000
$1.39
$76,450.00
Home